Diabetes

Ozempic Approved to Reduce Risk of Major Adverse Cardiovascular Events

Publish Date January 22, 2020

The FDA has approved a new indication for Ozempic (semaglutide; Novo Nordisk) injection to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.

Risk of Acute Kidney Injury With SGLT2 Inhibitors Investigated

Publish Date January 9, 2020

Sodium-glucose cotransporter-2 inhibitors (SGLT2is) do not appear to increase the risk of acute kidney injury (AKI), according to the findings of a recently published systematic review and meta-analysis. To evaluate the risk of AKI with these agents, study authors reviewed literature analyzing the effect of SGLT2is on renal adverse events compared with placebo or other…

Diabetes Mellitus May Increase Risk for Developing Heart Failure

Publish Date January 2, 2020

Increased risk for heart failure also seen in group of participants without diastolic dysfunction.

Many With Diabetes Engage in Underground Exchange of Medications, Supplies

Publish Date December 10, 2019

Diabetes-specific financial stress predicts engagement in trading, receiving donated meds, supplies.

Diagnosis of Treatment-Resistant Hypertension Predicts Mortality Outcomes in T2D

Publish Date October 30, 2019

For patients with type 2 diabetes, apparent treatment-resistant hypertension increases risk for cardiovascular events and mortality.

Duration of Diabetes History Tied to Higher Short-Term Mortality Risk

Publish Date December 11, 2019

Long-standing diabetes linked to higher risk for both all-cause and cardiovascular mortality.

Early-Onset CVD Rate Up for Children of Moms With Diabetes

Publish Date December 5, 2019

Rates of early-onset CVD higher for offspring of mothers with history of CVD, diabetes complications.

FDA Testing Levels of Carcinogen in Diabetes Drug Metformin

Publish Date December 10, 2019

No metformin recalls affect US market at the moment.

HbA1c Variability Linked to Cardiovascular Disease Risk

Publish Date November 19, 2019

Risks increased for all-cause mortality, cardiovascular events, microvascular complications.

WHO to Test, Approve Generic Insulin

Publish Date November 14, 2019

Agency says new generic versions could create competition that would drive down prices